One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules ...
AURORA, Colo., Oct. 28, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking ...
The "Human Leukocyte Antigen (HLA) Targeted Therapy, Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2026" report has been added to ResearchAndMarkets.com's offering. This report ...
The Epstein-Barr virus and a high-risk gene may work together to trick the immune system into attacking the brain in MS, a study suggests.
Cancer immunotherapy has revolutionized treatment for patients, whereby the body's own immune system is harnessed to destroy cancer cells. Typically, several molecules restrain the ability of T cells ...
The advances in molecular biology and genomic sequencing have helped in significantly increasing the accuracy, speed, and efficiency of HLA typing. Most of the conventional methods of serological ...
Biofortuna, a molecular diagnostics company with proprietary freeze drying (lyophilizing) technology, has received US FDA 510K clearance for its line of SSPGo HLA PCR kits. The SSPGo HLA Typing Kits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results